| Literature DB >> 30627250 |
Maziyar Mahdavi1,2, Saeed Rahimi3,4, Mahsa Eghlidospoor3.
Abstract
PURPOSE: Use of computed tomography (CT) has increased considerably all over the world. In addition, there has been an increased demand for utilisation of CT scanning in Iran over the past decade, especially after introducing multi-detector computed tomography (MDCT). It should be considered that making a mistake in the selection of scan parameters leads to patients receiving higher doses and having increased risk of cancer. All of these facts prompted us to compare six routine CT protocols in three hospitals in the city of Shiraz, and to compare the results with American College of Radiology (ACR) practice parameters and European Commission (EC) guidelines for dual- and multi-detector CT.Entities:
Keywords: CT dose; CT protocols; guideline; sequential CT; spiral CT
Year: 2018 PMID: 30627250 PMCID: PMC6323603 DOI: 10.5114/pjr.2018.77023
Source DB: PubMed Journal: Pol J Radiol ISSN: 1733-134X
Comparison of the detector collimation, slice thickness, and table increment in brain and sinus protocols with ACR and EC (16262) guidelines
| Guidelines and criteria | Slice thickness (mm) (detector collimation) | Table increment (mm) | ||
|---|---|---|---|---|
| Brain computed tomography | Post fossa | Mid brain to vertex | Post fossa | Mid brain to vertex |
| ACR | ≤ 5 | ≤ 5 | Contiguous | Contiguous |
| EC (16262) | 2-5 | 5-10 | Contiguous | Contiguous |
| PH | 5 (2*5) | 8 (2*8) | 10 | 16 |
| TH1 | 5 (2*5) | 10 (8*1.25) | 10 | 20 |
| 7.5 (8*1.25) | 15 | |||
| TH2 | 5 (2*5) | 5 (2*5) | 10 (2*5) | 10 |
| 10 (2*10) | 20 | |||
| EC (16262) | 3-5 | Contiguous | ||
| ACR | ≤ 1.5 | NQ | ||
| PH | 5 (2*5) | 10 | ||
| TH1 | 2.5 (8*1.25) | 2.5 (8*2.5) | 10 | 20 |
| TH2 | 5 (2*5) | 10 | ||
(+) means the parameter is compatible with guidelines, (–) means the parameter is incompatible with guidelines. NQ – the parameter is not mentioned quantitatively in the guidelines
Comparison of dose length products (DLP), dose reference level (DRL), and mean volume computed tomography dose indexes (CTDIvol) of sequential and spiral scans, respectively, in the three CT departments with ACR, EC (16262), and EC (2004)
| Guideline and criteria | Brain without contrast | Brain with contrast | Sinus | HRCTINS | HRCTEXP | Spiral chest | Spiral abdomen and pelvis | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ACR (DRL) | 75 mGy | 75 mGy | – | – | 21 mGy | 25 mGy | ||||||
| EC 16262 (DLP) | ≤ 1050 mGy . cm | ≤ 1050 mGy . cm | 360 mGy . cm | 280 mGy . cm | 650 mGy . cm | 1350 mGy . cm | ||||||
| EC 2004 (CTDIvol) | – | – | – | – | < 10 mGy | < 15 mGy | ||||||
| DLP | DRL | DLP | DRL | DLP | DLP | DLP* and (CTDIvol) | DRL | DLP* and (CTDIvol) | DRL | |||
| PH | Pt. 1-5 | 260 | 21.7 | 260* | 21.7 | 295.2 | 223 | NT | 397.8* | 17.5 | 650.3* | 15.7 |
| Pt. 6-10 | 272 | 23.7 | 272* | 23.7 | 290 | 225 | 385.1* | 17.4 | 708* | 17.4 | ||
| TH1 | Pt. 1-5 | 412.3 | 20.6 | 444.6* | 22.4 | 138.8 | 138.8 | 138.05 | 18.9 | 18.9 | 15.8 | 15.8 |
| Pt. 6-10 | 587.5 | 29.6 | 629.9* | 37.6 | 124.7 | 124.7 | 142.15 | 19.9 | 19.9 | 18.9 | 18.9 | |
| TH2 | Pt. 1-5 | 470.3 | 37.1 | 470.3* | 37.1 | 172.4 | 172.4 | 400 | 10.4 | 10.4 | 12.1 | 12.3 |
| Pt. 6-10 | 419.4 | 38 | 419.4* | 38 | 160.4 | 160.4 | 402.9 | 10.1 | 10.1 | 16.4 | 16.4 | |
Pt. – Patient, NT – the protocol is not taken in that hospital
Histories of 180 patients with sequential and spiral scans in three hospitals
| Hospital | Histories of patients (sequential and spiral scans) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Brain without contrast | Brain with contrast | Sinus | HRCT of lung inspiration | ||||||
| PH | Headache 80% | Tumour follow-up 50% | Headache 100% | CWI 60% | |||||
| Bronchiectasis 20% | |||||||||
| Trauma 20% | HNA 50% | Scleroderma 20% | |||||||
| TH1 | Trauma 40% | Brain tumour 50% | Headache 100% | CWI 100% | |||||
| SAH 40% | Tumour follow up 50% | ||||||||
| Headache and dizziness 20% | |||||||||
| TH2 | Trauma 40% | Trauma 40% | Headache 80% | Dysphonia 60% | |||||
| Headache 40% | Headache 30% | Trauma 20% | Chronic cough 40% | ||||||
| CVA 10% | EDH 5% | Decrease LOC 5% | EDH and CVA 30% | ||||||
| PH | Pneumonia 50% | Metastasis to abdominal organs 50% | |||||||
| Metastasis to thorax 50% | HNA 50% | ||||||||
| TH1 | Trauma 50% | SOL (Liver, gall bladder, ovary, appendix) 50% | |||||||
| Lung tumour 25% | Tumour 40% | ||||||||
| Metastasis to thorax 25% | Trauma 10% | ||||||||
| TH2 | Lung malignancy 50% | Abdominal mass 40% | |||||||
| Trauma 20% | Liver metastasis 30% | ||||||||
| PTE 10% | FUO 10% | Obstruction 10% | Trauma 20% | Polycystic kidney 10% | |||||
CWI – chemical war injury, HNA – history not available, SAH – subarachnoid haemorrhage, CVA – cerebrovascular accident, EDH – epidural haematoma, LOC – level of consciousness, SOL – space occupying lesion, PTE – pulmonary trunk emboli, FUO – fever with unknown origin
Comparison of the detector collimation, slice thickness, and pitch number of spiral chest and abdomen computed tomography (CT) with ACR and EC (16262) guidelines
| Spiral chest CT | Spiral abdomen and pelvis CT | |||||||
|---|---|---|---|---|---|---|---|---|
| Guideline & criteria | Slice thickness (mm) | Reconstruction | Pitch | Slice thickness (mm) | Reconstructioninterval (mm) | Pitchnumber | ||
| ACR | ≤ 5 (NQ) | NQ | NQ | ≤ 5 (NQ) | NQ | < 2 | ||
| EC (2004) | 1-2.5 (1-2.5) | 0 to 30% primary recon | 0.9-1.3 | Adopted to beam collimation | 0 to 50% | 0.9-1.3 | ||
| EC (16262) | 7-10 | Contiguous | 1-1.5 | 4-10 | 4-10 | 1-2 | ||
| Hospital | 6.5 (2*5) | 9 | 0.8 | 8 (2*6) | 8 | 1.75 | ||
| TH1 | 5 (8*2.5) | 5 | 1.675 | 5 (8*2.5) | 5 | 1.35 | ||
| TH2 | 7.5 (16*1.25) | 7.5 | 1.75 | 7.5 (16*1.25) | 5 (16*1.25) | 7.5 | 5 | 1.75 |
NQ – the parameter is not mentioned quantitatively in the guidelines. (+) means the parameter is compatible with guidelines, (–) means the parameter is incompatible with guidelines